POSSIBILITIES OF RADIUM-223 APPLICATION IN THERAPY OF PROSTATE GLAND CANCER

by A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV
Published 2017-06-01

POSSIBILITIES OF A COMBINATION OF DOCETAXEL WITH ANDROGEN DEPRIVATION IN INITIAL THERAPY OF HORMONESENSITIVE PROSTATE CANCER

by A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV
Published 2017-06-01

THE PLACE OF ENZALUTAMIDE IN THE SERIAL TREATMENT OF TREATMENT-RESISTANT PROSTATE CANCER

by A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV
Published 2017-06-01

DEVELOPMENT AND CLINICAL EFFECTIVENESS OF ANTIANDROGENS IN THE TREATMENT OF ADVANCED PROSTATE CANCER

by S. V. MISHUGIN, A. A. GRITSKEVICH, I. G. RUSAKOV
Published 2016-12-01

Mesto khimioterapii i gormonoterapii vo 2-y linii lecheniya kastratsionno-rezistentnogo raka predstatel'noy zhelezy

by I G Rusakov, A A Gritskevich, S V Mishugin
Published 2012-09-01

Еfficiacy and safety of radium-223 in the treatment of metastatic castration-resistant prostate cancer

by I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, S. V. Mishugin
Published 2020-12-01

The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy

by I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, S. V. Mishugin
Published 2020-12-01

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

by T. N. Skvortsova, S. V. Mishugin, A. A. Gritskevich, I. G. Rusakov
Published 2017-01-01

Study of the economic efficiency of the combined method of Octreotide-depo + dexamethasone therapy in the treatment of patients with castration-resistant prostate cancer

by S. V. Mishugin, I. G. Rusakov, I. V. Novikova, A. A. Gritskevich
Published 2019-06-01

EVALUATION OF EFFECT OF PROLONGED ACTION SOMATOSTATIN ANALOGUE – OCREOTIDE-DEPO – ON THE FOLLOWING HORMONAL AND CYTOTOXIC THERAPY IN PATIENTS WITH METASTATIC CASTRATE-RESIS...

by S. V. Mishugin, A. A. Gritskevich, A. A. Mordovin, I. G. Rusakov
Published 2017-11-01

CLINICAL ASSESSMENT OF TAXANES IN THE FIRST-LINE CYTOTOXIC THERAPY OF CASTRATION-RESISTANT PROSTATE CANCER

by A. A. GRITSKEVICH, S. V. MISHUGIN, A. A. TEPLOV, I. G. RUSAKOV
Published 2016-12-01

Taxoter as a new standard for treatment of hormone-refractory prostate cancer

by I. G. Rusakov, B. Ya. Alekseyev, G. V. Vereshagina, A. A. Gritskevich
Published 2020-02-01

The role of sunitinib in the therapy of metastatic renal cell carcinoma

by I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, A. N. Shipilova, S. V. Mishugin
Published 2020-07-01

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER

by A. A. Gritskevich, V. L. Medvedev, S. V. Mishugin, N. A. Apolskaya, I. G. Rusakov
Published 2017-02-01

The role of Buserelin in the treatment of advanced prostate cancer (APC)

by S. V. Mishugin, A. A. Drobyazko, A. A. Mordovin, A. A. Gritskevich, I. G. Rusakov
Published 2015-12-01

The role of prostate-specific antigen in the prediction of hormone-sensitive prostate cancer

by A. A. Gritskevich, S. V. Mishugin, A. A. Teplov, V. L. Medvedev, I. G. Rusakov
Published 2015-12-01

Effective suppression of testosterone: the best castration therapy for hormone-sensitive prostate cancer?

by A. A. Gritskevich, S. V. Mishugin, A. A. Teplov, V. L. Medvedev, I. G. Rusakov
Published 2015-12-01

Еxtracorporeal partial nephrectomy with orthotopic autotransplantation in conditions of pharmaco-cold ischemia for a single kidney cancer

by T.P. Baitman, A.A. Teplov, A.A. Gritskevich, I.V. Miroshkina, M.V. Morozova
Published 2020-07-01

Ex vivo kidney resection in pharmacological cold ischemia followed by orthotopic autotransplantation

by A. A. Gritskevich, S. S. P'yanikin, Z. A. Adyrkhaev, Yu. A. Stepanova, V. V. Kazennov, A. E. Zotikov, A. A. Teplov, A. Sh. Revishvili
Published 2016-09-01